Inhaling respirable crystalline silica dust

Rheumatoid arthritis - Inhaling respirable crystalline silica dust Factor

Last reviewed for CCPS 22 December 2008.

Investigative Documents

Claimant Report - Inhaling Respirable Crystalline Silica Dust - Rheumatoid Arthritis [CR9309]

Preliminary questions [34579]

24551

there is some evidence that inhaling respirable crystalline silica dust may be a factor in the development or worsening of the condition under consideration.

34641 the veteran has inhaled respirable crystalline silica dust as defined in the Statements of Principles for rheumatoid arthritis at some time.

40346the veteran has established the causal connection between inhaling respirable crystalline silica dust and VEA service for rheumatoid arthritis.

34642the veteran has established the causal connection between inhaling respirable crystalline silica dust and VEA service for the clinical onset of rheumatoid arthritis.

34643the veteran has established the causal connection between inhaling respirable crystalline silica dust and operational service for the clinical onset of rheumatoid arthritis.

or

34644the veteran has established the causal connection between inhaling respirable crystalline silica dust and eligible service for the clinical onset of rheumatoid arthritis.

or

7334

the clinical onset of the condition under consideration occurred after the end of the veteran's last period of VEA service.

7335

the condition under consideration permanently worsened.

40347the veteran has established the causal connection between inhaling respirable crystalline silica dust and VEA service for the clinical worsening of rheumatoid arthritis.

40348the veteran has established the causal connection between inhaling respirable crystalline silica dust and operational service for the clinical worsening of rheumatoid arthritis.

or

40349the veteran has established the causal connection between inhaling respirable crystalline silica dust and eligible service for the clinical worsening of rheumatoid arthritis.

Clinical onset and operational service [34643]

34645

the veteran has inhaled respirable crystalline silica dust as defined in the Statements of Principles for rheumatoid arthritis for a cumulative period of at least 2500 hours within a continuous period of ten years.

34646

the veteran inhaled respirable crystalline silica dust as defined in the Statements of Principles for rheumatoid arthritis for a cumulative period of at least 2500 hours within a continuous period of ten years before the clinical onset of rheumatoid arthritis.

34647

operational service made a material contribution to the veteran's inhalation of respirable crystalline silica dust as defined in the Statements of Principles for rheumatoid arthritis for a cumulative period of at least 2500 hours within a continuous period of ten years before the clinical onset of rheumatoid arthritis.

Clinical onset and eligible service [34644]

34648

the veteran has inhaled respirable crystalline silica dust as defined in the Statements of Principles for rheumatoid arthritis for a cumulative period of at least 5000 hours within a period of ten years.

34649

the veteran inhaled respirable crystalline silica dust as defined in the Statements of Principles for rheumatoid arthritis for a cumulative period of at least 5000 hours within the ten years before the clinical onset of rheumatoid arthritis.

34650

eligible service made a material contribution to the veteran's inhalation of respirable crystalline silica dust as defined in the Statements of Principles for rheumatoid arthritis for a cumulative period of at least 5000 hours within the ten years before the clinical onset of rheumatoid arthritis.

Clinical worsening and operational service [40348]

34645

the veteran has inhaled respirable crystalline silica dust as defined in the Statements of Principles for rheumatoid arthritis for a cumulative period of at least 2500 hours within a continuous period of ten years.

40350

the veteran inhaled respirable crystalline silica dust as defined in the Statements of Principles for rheumatoid arthritis for a cumulative period of at least 2500 hours within a continuous period of ten years after the clinical onset and before the clinical worsening of rheumatoid arthritis.

40351

operational service made a material contribution to the veteran's inhalation of respirable crystalline silica dust as defined in the Statements of Principles for rheumatoid arthritis for a cumulative period of at least 2500 hours within a continuous period of ten years after the clinical onset and before the clinical worsening of rheumatoid arthritis.

Clinical worsening and eligible service [40349]

34648

the veteran has inhaled respirable crystalline silica dust as defined in the Statements of Principles for rheumatoid arthritis for a cumulative period of at least 5000 hours within a period of ten years.

40352

the veteran inhaled respirable crystalline silica dust as defined in the Statements of Principles for rheumatoid arthritis for a cumulative period of at least 5000 hours after the clinical onset of rheumatoid arthritis and within the ten years before its clinical worsening.

40353

eligible service made a material contribution to the veteran's inhalation of respirable crystalline silica dust as defined in the Statements of Principles for rheumatoid arthritis for a cumulative period of at least 5000 hours after the clinical onset of rheumatoid arthritis and within the ten years before its clinical worsening.

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/q-z/rheumatoid-arthritis-n026-m05m06/rulebase-rheumatoid-arthritis/inhaling-respirable-crystalline-silica-dust